Because STAT3 activation contributes to the GBM immunosuppressive microenvironment, this raises the possibility that STAT3, in cooperation with the heterogenous cell population of the tumor microenvironment, suppresses PRKAA/AMPKα to influence the metabolic cues that support tumor growth. The gene discussed is PRKAA2; the disease is neoplasm.